Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Acer Therapeutics Inc
ACER
Healthcare
Acer Therapeutics Inc ???????,?????????????????????????????,??????????????????????????OLPRUVA(????)?ACER-801(????)?EDSIVO(????)???????OLPRUVA(????)?????????,?????????????,????????(UCDs)??????(MSUD)??ACER-801(????)????????????????(NK3R)???,????????(VMS)????????(PTSD)???????EDSIVO(????)??????????????,???????III?????(COL3A1)????????Ehlers-Danlos???(vEDS)?
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:ACER)
New Post
View:
Posts & Comments
Threaded Posts
(14)
•••
allison5120
X
View Profile
View Bullboard History
Post by
allison5120
on Jan 31, 2020 10:45pm
Acer Therapeutics new article on Seeking Alpha Jan 31 2020
See https://seekingalpha.com/article/4320604-acer-therapeutics-upcoming-catalysts "... Acer has a number of upcoming catalysts including a possible positive appeal outcome for EDSIVO
...more
(111)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Jun 28, 2019 11:36am
added more of this one
yesterday and today,using dollar cost averaging,so glta.
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company
posted Dec 22, 2024 9:00am by
Voyageur Pharmaceuticals Ltd
-
|
Voyageur is securing supply chains in North America for barium, iodine and fullerene drug development and is aiming to gain efficiencies in production of contrast media products. The company anticipates this LOI will expand Voyageur’s project portfolio and diversify the Company’s product mix. The global contrast media market is valued at $6.3 billion with GE HealthCare projecting it will double over the next decade. ...read more
(111)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Jun 25, 2019 1:17pm
it's a buy today for me
at $ 4.28 per share,so glta,it's way oversold,and it's down 15 dollars per share,it merged with oxera last year,so it is cheap,looking for a dead cat bounce at least.
(14)
•••
allison5120
X
View Profile
View Bullboard History
Post by
allison5120
on Jun 11, 2019 4:35pm
Acer Therapeutics new article on Seeking Alpha
I published a new article on Seeking Alpha "Acer Therapeutics: Concerns Prior to Upcoming PDUFA date", See https://seekingalpha.com/article/4269714-acer-therapeutics-concerns-prior
...more
(14)
•••
allison5120
X
View Profile
View Bullboard History
Post by
allison5120
on Sep 25, 2018 8:27am
Acer summary from SA article
Summary from SA article this morning: "... Summary Acer is building a pharmaceutical company focused on acquiring, developing and commercializing orphan and ultra-orphan drugs to treat rare
...more
(14)
•••
allison5120
X
View Profile
View Bullboard History
Post by
allison5120
on Sep 25, 2018 8:25am
Acer summary from SA article
Summary from Seeking Alpha article this morning, "...Acer is building a pharmaceutical company focused on acquiring, developing and commercializing orphan and ultra-orphan drugs to treat rare
...more
(14)
•••
allison5120
X
View Profile
View Bullboard History
Post by
allison5120
on Sep 25, 2018 8:24am
Acer Therapeutics - new article on Seeking Alpha
See new article on Seeking Alpha on $ACER. Potentially very lucrative business model. 2 drugs in pipeline. EDSIVO - could be filing NDA as early as October, 2018 with potential PDUFA date in late Q2
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments